Related Experiment Video
Updated: Jun 24, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Remifentanil in paediatric anaesthetic practice
1Department of Anaesthesia, Queen Alexandra Hospital, Portsmouth, UK. debbie.marsh@porthosp.nhs.uk
Anaesthesia
|March 24, 2009
Summary
Remifentanil, a potent synthetic opioid, offers predictable anesthesia in pediatric patients due to its rapid clearance and lack of accumulation. Its unique pharmacokinetic profile makes it ideal for various age groups, especially neonates and infants.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Remifentanil is a synthetic opioid introduced in 1996.
- Its unique pharmacokinetic profile has increased its use in pediatric anesthesia.
Purpose of the Study:
- To highlight the benefits of remifentanil in pediatric anesthesia.
- To discuss its pharmacokinetic advantages for various age groups.
Main Methods:
- Review of remifentanil's pharmacokinetic properties.
- Analysis of its clinical application in pediatric patients.
Main Results:
- Remifentanil exhibits high potency and rapid clearance, preventing accumulation.
- It offers predictable anesthetic effects across a wide age range, from neonates to the elderly.
- Neonates and infants demonstrate higher clearance rates, enhancing remifentanil's benefits in this population.
Conclusions:
- Remifentanil is a highly predictable opioid for pediatric anesthesia.
- Its pharmacokinetic profile makes it a valuable tool for diverse anesthetic challenges in children.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...